AngioDynamics, Inc. (ANGO)
15.87
-0.26
(-1.61%)
USD |
NASDAQ |
Sep 01, 16:00
15.87
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Cash from Operations (Annual) : 3.089M for May 31, 2026
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| May 31, 2026 | 3.089M |
| May 31, 2025 | -10.81M |
| May 31, 2024 | -28.16M |
| May 31, 2023 | 0.078M |
| May 31, 2022 | -7.194M |
| May 31, 2021 | 24.09M |
| May 31, 2020 | -14.55M |
| May 31, 2019 | 37.44M |
| May 31, 2018 | 41.29M |
| May 31, 2017 | 55.74M |
| May 31, 2016 | 45.22M |
| May 31, 2015 | 26.24M |
| May 31, 2014 | 24.68M |
| May 31, 2013 | 26.88M |
| Date | Value |
|---|---|
| May 31, 2012 | 11.50M |
| May 31, 2011 | 33.87M |
| May 31, 2010 | 39.96M |
| May 31, 2009 | 19.94M |
| May 31, 2008 | 25.91M |
| May 31, 2007 | 8.784M |
| May 31, 2006 | 3.219M |
| May 31, 2005 | 4.788M |
| May 31, 2004 | 2.50M |
| May 31, 2003 | 0.68M |
| May 31, 2002 | 1.206M |
| May 31, 2001 | 0.409M |
| May 31, 2000 | 0.40M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp. | 4.534B |
| Penumbra, Inc. | 238.66M |
| Abbott Laboratories | 9.566B |
| Alphatec Holdings, Inc. | 45.23M |
| AtriCure, Inc. | 57.33M |